{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:30:37Z","timestamp":1780497037915,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"European research program FEDER","award":["2014-34018"],"award-info":[{"award-number":["2014-34018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00228-020-02974-1","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T09:13:51Z","timestamp":1596273231000},"page":"1765-1772","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Drug exposure for PDA closure in France: a prospective, cohort-based, analysis"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6243-0909","authenticated-orcid":false,"given":"Silvia","family":"Iacobelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Lorrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Gouyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Laforgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Bernard","family":"Gouyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bonsante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,1]]},"reference":[{"issue":"3","key":"2974_CR1","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5863\/1551-6776-12.3.138","volume":"12","author":"JE Dice","year":"2007","unstructured":"Dice JE, Bhatia J (2007) Patent ductus arteriosus: an overview. J Pediatr Pharmacol Ther 12(3):138\u2013146. https:\/\/doi.org\/10.5863\/1551-6776-12.3.138","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"4","key":"2974_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1159\/000454798","volume":"111","author":"A-K Edstedt Bonamy","year":"2017","unstructured":"Edstedt Bonamy A-K, Gudmundsdottir A, Maier RF, Toome L, Zeitlin J, Bonet M, Fenton A, Hasselager AB, van Heijst A, Gortner L, Milligan D, van Reempts P, Boyle EM, Norman M, and collaborators from the EPICE Research Group (2017) Patent ductus arteriosus treatment in very preterm infants: a European population-based cohort study (EPICE) on variation and outcomes. Neonatology 111(4):367\u2013375. https:\/\/doi.org\/10.1159\/000454798","journal-title":"Neonatology"},{"key":"2974_CR3","doi-asserted-by":"publisher","unstructured":"Group Express. Incidence of and risk factors for neonatal morbidity after active perinatal care: extremely preterm infants study in Sweden (EXPRESS) (2010). Acta Paediatr 99(7): 978\u2013992. doi: https:\/\/doi.org\/10.1111\/j.1651-2227.2010.01846","DOI":"10.1111\/j.1651-2227.2010.01846"},{"issue":"5","key":"2974_CR4","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1542\/peds.2009-3506","volume":"125","author":"SEG Hamrick","year":"2010","unstructured":"Hamrick SEG, Hansmann G (2010) Patent ductus arteriosus of the preterm infant. Pediatrics 125(5):1020\u20131030. https:\/\/doi.org\/10.1542\/peds.2009-3506","journal-title":"Pediatrics"},{"key":"2974_CR5","doi-asserted-by":"publisher","first-page":"007","DOI":"10.4172\/2161-105X.S13-007","volume":"13","author":"B Sinha","year":"2013","unstructured":"Sinha B (2013) Controversies in management of patent ductus arteriosus in the preterm infant. J Pulmon Resp Med S 13:007. https:\/\/doi.org\/10.4172\/2161-105X.S13-007","journal-title":"J Pulmon Resp Med S"},{"key":"2974_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4172\/2167-0897.1000238","volume":"5","author":"N Chaudhary","year":"2016","unstructured":"Chaudhary N, Filipov P, Bhutada A, Rastogi S (2016) Controversies in the management of patent ductus arteriosus in preterm infants. J Neonatal Biol 5:238. https:\/\/doi.org\/10.4172\/2167-0897.1000238","journal-title":"J Neonatal Biol"},{"issue":"24","key":"2974_CR7","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1001\/jama.2015.6734","volume":"313","author":"JC Roz\u00e9","year":"2015","unstructured":"Roz\u00e9 JC, Cambonie G, Marchand-Martin L, Gournay V, Durrmeyer X, Durox M, Storme L, Porcher R, Ancel PY, Hemodynamic EPIPAGE 2 Study Group (2015) Association between early screening for patent ductus arteriosus and in-hospital mortality among extremely preterm infants. JAMA 313(24):2441\u20132448. https:\/\/doi.org\/10.1001\/jama.2015.6734","journal-title":"JAMA"},{"issue":"1","key":"2974_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/jcpt.12474","volume":"42","author":"B Gouyon","year":"2017","unstructured":"Gouyon B, Iacobelli S, Saliba E, Quantin C, Pignolet A, Jacqz-Aigrain E, Gouyon JB (2017) A computer prescribing. Order entry-clinical decision support system designed for neonatal care: results of the \u2018preselected prescription\u2019 concept at the bedside. J Clin Pharm Ther 42(1):64\u201368. https:\/\/doi.org\/10.1111\/jcpt.12474","journal-title":"J Clin Pharm Ther"},{"issue":"9","key":"2974_CR9","doi-asserted-by":"publisher","first-page":"e0222667","DOI":"10.1371\/journal.pone.0222667","volume":"14","author":"B Gouyon","year":"2019","unstructured":"Gouyon B, Martin-Mons S, Iacobelli S, Razafimahefa H, Kermorvant-Duchemin E, Brat R, Caeymaex L, Couringa Y, Alexandre C, Lafon C, Ramful D, Bonsante F, Binson G, Flamein F, Moussy-Durandy A, di Maio M, Mazeiras G, Girard O, Desbruyeres C, Mourdie J, Escourrou G, Flechelles O, Abasse S, Rosenthal JM, Pages AS, Dorsi M, Karaoui L, ElGellab A, le Bail Dantec F, Yangui MA, Norbert K, Kugbe Y, Lorrain S, Pignolet A, Garnier EM, Lapillonne A, Mitanchez D, Jacqz-Aigrain E, Gouyon JB (2019) Characteristics of prescription in 29 Level 3 Neonatal Wards over a 2-year period (2017-2018). An inventory for future research. PLoS One 14(9):e0222667. https:\/\/doi.org\/10.1371\/journal.pone.0222667","journal-title":"PLoS One"},{"key":"2974_CR10","unstructured":"Taketomo CKHJH, Kraus DM (2016) Pediatric and neonatal dosage handbook. Lexicomp. 23th ed. Hudson: Wolters Kluwer Clinical Druf Information"},{"key":"2974_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.earlhumdev.2019.06.002","volume":"135","author":"C Dani","year":"2019","unstructured":"Dani C, Mosca F, Cresi F, Lago P, Lista G, Laforgia N, del Vecchio A, Corvaglia L, Paolillo P, Trevisanuto D, Capasso L, Fanos V, Maffei G, Boni L (2019) Patent ductus arteriosus in preterm infants born at 23\u201324 weeks\u2019 gestation: should we pay more attention? Early Hum Dev 135:16\u201322. https:\/\/doi.org\/10.1016\/j.earlhumdev.2019.06.002","journal-title":"Early Hum Dev"},{"key":"2974_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/pr.2014.82","volume":"76","author":"A El-Khuffash","year":"2014","unstructured":"El-Khuffash A, Jain A, Corcoran D, Shah PS, Hooper CW, Brown N et al (2014) Efficacy of paracetamol on patent ductus arteriosus closure may be dose dependent: evidence from human and murine studies. Pediatr Res 76:238\u2013244. https:\/\/doi.org\/10.1038\/pr.2014.82","journal-title":"Pediatr Res"},{"issue":"4","key":"2974_CR13","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.siny.2015.03.004","volume":"20","author":"N Evans","year":"2015","unstructured":"Evans N (2015) Preterm patent ductus arteriosus: a continuing conundrum for the neonatologist? Semin Fetal Neonatal Med 20(4):272\u2013277. https:\/\/doi.org\/10.1016\/j.siny.2015.03.004","journal-title":"Semin Fetal Neonatal Med"},{"key":"2974_CR14","doi-asserted-by":"publisher","unstructured":"Kluckow M, Jeffery M, Gill A, Evans N (2014) A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 99(2):F99\u2013104. doi: https:\/\/doi.org\/10.1136\/archdischild-2013-304695","DOI":"10.1136\/archdischild-2013-304695"},{"key":"2974_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1055\/s-0033-1361933","volume":"31","author":"EM Hsieh","year":"2014","unstructured":"Hsieh EM, Hornik CP, Clark RH, Laughon MM, Benjamin DK, Smith P (2014) Medication use in the neonatal intensive care unit. Am J Perinatol 31:811\u2013822. https:\/\/doi.org\/10.1055\/s-0033-1361933","journal-title":"Am J Perinatol"},{"issue":"1","key":"2974_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1442-200X.2009.02886.x","volume":"52","author":"C Gimpel","year":"2010","unstructured":"Gimpel C, Krause A, Franck P, Krueger M, von Schnakenburg C (2010) Exposure to furosemide as the strongest risk factor for nephrocalcinosis in preterm infants. Pediatr Int 52(1):51\u201356. https:\/\/doi.org\/10.1111\/j.1442-200X.2009.02886.x","journal-title":"Pediatr Int"},{"key":"2974_CR17","doi-asserted-by":"publisher","first-page":"CD000503","DOI":"10.1002\/14651858","volume":"12","author":"EF Bell","year":"2014","unstructured":"Bell EF, Acarregui MJ (2014) Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 12:CD000503. https:\/\/doi.org\/10.1002\/14651858","journal-title":"Cochrane Database Syst Rev"},{"key":"2974_CR18","doi-asserted-by":"crossref","unstructured":"Vanhaesebrouck S, Zonnenberg I, Vandervoort P, Bruneel E, Van Hoestenberghe MR, Theyskens C (2007) Conservative treatment for patent ductus arteriosus in the preterm. Archives of Disease in Childhood - Fetal and Neonatal Edition 92 (4):F244-F247","DOI":"10.1136\/adc.2006.104596"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-02974-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-020-02974-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-02974-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T23:40:23Z","timestamp":1627774823000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-020-02974-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2974"],"URL":"https:\/\/doi.org\/10.1007\/s00228-020-02974-1","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,1]]},"assertion":[{"value":"3 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Competing interests: Dr. Beatrice Gouyon (3rd author) was in charge of the B-PEN program (Benchmarking of Prescription in Neonatology) in the research center (CEPOI) from 2012 to 2016. Her employer was the University Hospital (CHU) of La R\u00e9union. Then Dr. B Gouyon left the CEPOI to take the lead of a new start-up (LogipremF comp.) responsible for the development of the prescription software Logipren and its implementation in the NICUs of the B-PEN network. This change of affiliation has been contracted with the University Hospital of La R\u00e9union, after authorization from the \u201cCommission de D\u00e9ontologie de la Fonction Publique\u201d was obtained. Dr. B Gouyon remained closely involved in the research projects issued from the B-PEN database particularly. All other authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with French legislation. As per French law applicable to trials involving human subjects (Jard\u00e9 Act), a specific approval of an ethics committee is not required for this non-interventional study based on anonymized data of authorized collections (declaration number CNIL: DE-2015-099, DE-2017-410).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors approved the final manuscript and gave consent for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}